Neuropsychological and Behavioral Testing in Younger Patients With Cancer

Inclusion Criteria:

   - The patient must be currently be enrolled or plan to be enrolled on a COG therapeutic
   study that aims to examine neuropsychological, social, emotional, and/or behavioral
   functioning

   - The patient must have receptive and expressive language skills in English, French, or
   Spanish; if a patient meets these criteria but the parent/guardian speaks a language
   other than English, French, or Spanish, the patient may still be enrolled and tested,
   and the parent-report measures should be omitted

   - All patients and/or their parents or legal guardians must sign a written informed
   consent

   - All institutional, Food and Drug Administration (FDA), and National Cancer Institute
   (NCI) requirements for human studies must be met

Exclusion Criteria:

   - Patients with a history of moderate to profound intellectual disability (i.e.
   intelligence quotient [IQ] =< 55) are not eligible for enrollment; PLEASE NOTE:
   Children with a prior history of attention deficit hyperactivity disorder (ADHD) or a
   specific learning disability (e.g., dyslexia) are eligible for this study